Skip to content

Studies on the molecular mechanisms of neurodegenerative diseases

Studies on the molecular mechanisms of neurodegenerative diseases

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089515
Enrollment
Unknown
Registered
2024-09-10
Start date
2025-01-01
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Interventions

Sponsors

Shanghai Fourth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: Patients with Parkinson's disease at different stages; The conditions of all patients were consistent with the diagnostic criteria of Chinese Classification and Diagnostic Criteria for Mental Disorders (3rd edition), and all patients had anxiety and depression. The patient had no serious physical illness

Exclusion criteria

Exclusion criteria: Patients with a past history of mental illness or other mental disorders; Patients with Parkinson plus syndrome; People with severe dementia and speech disorders; Patients who did not consent to sign samples for experimental studie

Design outcomes

Primary

MeasureTime frame
Chromogranin A expression level;

Secondary

MeasureTime frame
Expression levels of a-Synuclein;

Countries

China

Contacts

Public ContactQihui Wu

Shanghai Fourth People's Hospital (Shanghai Fourth People's Hospital Affiliated to Tongji University)

qihuiwu@tongji.edu.cn+86 188 1051 0109

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026